Expression ratio of CCND1 to CDKN2A mRNA predicts RB1 status of cultured cancer cell lines and clinical tumor samples
<p>Abstract</p> <p>Background</p> <p>The retinoblastoma product (RB1) is frequently deregulated in various types of tumors by mutation, deletion, or inactivation through association with viral oncoproteins. The functional loss of RB1 is recognized to be one of the hallm...
Main Authors: | Itadani Hiraku, Komatani Hideya, Kobayashi Tsutomu, Machida Takumitsu, Mizuarai Shinji, Kotani Hidehito |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-03-01
|
Series: | Molecular Cancer |
Online Access: | http://www.molecular-cancer.com/content/10/1/31 |
Similar Items
-
Discovery of gene expression-based pharmacodynamic biomarker for a p53 context-specific anti-tumor drug Wee1 inhibitor
by: Mizuarai Shinji, et al.
Published: (2009-06-01) -
Inhibition of p70S6K2 down-regulates Hedgehog/GLI pathway in non-small cell lung cancer cell lines
by: Kotani Hidehito, et al.
Published: (2009-07-01) -
Mouse gastric tumor models with prostaglandin E<sub>2 </sub>pathway activation show similar gene expression profiles to intestinal-type human gastric cancer
by: Oshima Masanobu, et al.
Published: (2009-12-01) -
Prognostic Importance of Cell Cycle Regulators Cyclin D1 (CCND1) and Cyclin-Dependent Kinase Inhibitor 1B (CDKN1B/p27) in Sporadic Gastric Cancers
by: Petra Minarikova, et al.
Published: (2016-01-01) -
Ribosomal protein L19 regulates CCND1 protein expression and cell cycle progression through interacting with the internal ribosome entry site located on the 5’UTR of CCND1 mRNA
by: Ping-HanChung, et al.
Published: (2012)